Pricing options

Select your option depending on whether you require CE credits.

To obtain your certificate, the CE form must be filled out within 14 days of class completion.

Program Description

Live-Online Webinar 10AM - 5PM Eastern, May 1 & 2, 2021

  • Ketamine is a dissociative anesthetic also classified as a psychedelic. In the last decade it has become frequently sought as a treatment for depression and mood disorders. This training is designed for therapists, psychologists, physicians, and other healthcare professionals who want to better understand the basics of ketamine and how they can ensure the best clinical outcomes for patients.

  • While ketamine is a powerful and promising treatment, effective and safe treatment involves far more than administering the drug itself. This course will teach medical professionals and mental health care providers how they can help their patients safely and legally access ketamine treatment, as well as prepare for and integrate those treatments using a psychedelic-assisted therapy framework.

  • Participants in this course will learn principles for screening and preparing patients for ketamine treatment, and integrating the insights generated from their experiences into follow up psychotherapy. We introduce a variety of care models including ketamine-assisted therapy, ketamine infusions paired with preparation and integration provided by a separate therapist.

  • The presenters of this course will present case examples and opportunities to practice real-world discussions role-play exercises. While an overview of infusion session procedures and ketamine effects is provided, complete ketamine administration instructions for medical professionals is beyond the scope of this course.

Learning Objectives

  • Describe the concepts of Drug Assisted Therapy to their clients

  • Describe how ketamine fits into treatment plans for depressive disorders

  • Apply and Integrate ketamine into their existing frameworks for managing clients with depressive disorders

  • Describe the current understandings of ketamine antidepressant mechanisms

  • Describe clients that might be appropriate for ketamine infusion therapy

  • Describe clients that might NOT be appropriate for ketamine infusion therapy

  • List the legal and practical hurdles in accessing this treatment for their clients

  • List the differences between the medical and recreational use of ketamine

  • Plan how to psychologically prepare their clients for the ketamine sessions

  • Prepare their clients in integrating the experiences from the ketamine sessions into their larger psychotherapeutic goals

  • Demonstrate specific psychotherapeutic techniques to maximize behavioral and cognitive changes during the neuroplastic windows opened by ketamine

  • Describe how ketamine could play a long term role in mental healthcare

Resources

Registration includes access to our online classroom, course handouts, and private course discussion board. All attendees may opt to be added to our professional community email list of over 600 professionals who have completed this (or similar) courses with us.

Certificate Program

This course can be taken in partial fulfillment of the requirements for the Fluence Postgraduate Certificate in Ketamine-assisted Psychotherapy.

Instructors

Lead Trainer

Elizabeth Nielson, PhD

Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment PTSD, and psilocybin-assisted treatment of treatment resistant depression. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her program of research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.

Lead Trainer

Ingmar Gorman, PhD

Dr. Ingmar Gorman is a psychologist who specializes in helping people who use psychedelics and other psychoactive compounds. He received his clinical training at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University in 2017. Dr. Gorman was formerly the Director of the Psychedelic Education and Continuing Care Program at the Center for Optimal Living and is now the co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. Along with Dr. Paleos, he is currently site co-principal investigator and therapist on a Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder.

Lead Trainer

Casey Paleos, MD

Casey Paleos, MD is a psychiatrist and researcher with over a decade of experience in the use of psychedelic medicines for the treatment of mental illness, dating back to his work, while still in residency training, as a study therapist in the landmark Psilocybin Cancer Anxiety Study at NYU, where Dr. Guss was one of his mentors. Since then, Dr. Paleos was Co-Principal Investigator in the NYU-Bellevue Ketamine for Depression Study and has been treating patients in his private practice with both ketamine infusion therapy and ketamine-assisted psychotherapy since 2016. Presently, he is a study therapist and Principal Investigator, alongside Dr. Gorman, in the MAPS-sponsored MDMA-Assisted Psychotherapy for PTSD Phase 3 Clinical Trial, serves as Scientific Director at Mindbloom, Inc., and is a co-founder of Nautilus Sanctuary, a non-profit psychedelic research and clinical institution based in New York City.

Accreditation

Continuing Education Credits for Health Professionals (CE)

  • CE credits for psychologists are provided by the Spiritual Competency Resource Center (SCRC) which is co-sponsoring this program. The Spiritual Competency Resource Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The Spiritual Competency Resource Center maintains responsibility for this program and its content.

  • The California Board of Behavioral Sciences accepts CE credits for LCSW, LPCC, LEP, and LMFT license renewal for programs offered by approved sponsors of CE by the American Psychological Association.

  • LCSWs, MFTs, and other mental health professionals from states other than California need to check with their state licensing board as to whether or not they accept programs offered by approved sponsors of CE by the American Psychological Association.

  • SCRC is approved by the California Board of Registered Nursing (BRN Provider CEP16887) for licensed nurses in California.

  • For questions about receiving your Certificate of Attendance, contact David Gumpel, david@fluence8.com. For questions about CE, visit www.spiritualcompetency.com or contact David Lukoff, PhD at CE@spiritualcompetency.com.

Continuing Medical Education (CME) for Medical Professionals

  • Continuing Medical Education (CME) Accreditation pending, please check this page again soon for details

Accreditation and Affiliation

Spiritual Competency Resource Center
American Association for Adult and Continuing Education